Loading company…
Clinical genomics software company, founded in 2014, whose Clinical Genomics Workspace supports genomic analysis and reporting.
PierianDx provides a Clinical Genomics Workspace that supports the analysis of genomic findings and the creation of reports, with subscription pricing and professional services such as assay selection and clinical interpretation. Founded in 2014 in the US, it is listed at Late stage. Summa Equity acquired the company in 2022, and it has raised USD 27.00 mn in Series B funding across 5 deals, with investors including ARUP Laboratories and Health Catalyst Capital Management. It operates under the Velsera brand and serves laboratories and healthcare providers.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in